Abstract
Purpose
The purpose of this study was to investigate the feasibility and effectiveness of high-dose planned adaptive intensity-modulated radiation therapy (IMRT) with helical tomotherapy (HT) for cutaneous angiosarcoma (cAS) of the scalp.
Methods
This retrospective cross-sectional included a total of 12 consecutive patients with cAS of the scalp who underwent high-dose planned adaptive IMRT with HT. Prescribed doses were 72.5–74 Gy in 35–37 fractions for the gross tumor volume plus a 1–2 mm margin (PTV1), 58–60 Gy in 29–30 fractions for the clinical target volume plus a 2–3 mm margin (PTV2), and 46 Gy in 23 fractions for the clinical target volume plus a 5–15 mm margin (PTV3) over periods of 7.5, 6 and 4.5 weeks, respectively.
Results
The estimated 1‑year and 2‑year overall survival rate were 65.6% and 27.3%, respectively, and the local progression-free survival at 2 years was 74.1%. All local recurrences were either in or marginal to the PTV2 or PTV3. No local recurrence was observed in the PTV1. All patients tolerated the treatment without grade 3 or higher adverse events during the radiotherapy period. No late adverse events were observed during the follow-up period.
Conclusion
Planned adaptive high-dose IMRT with HT has the potential to improve local control rate without increasing adverse events.
Similar content being viewed by others
References
Ishida Y, Otsuka A, Kabashima K (2018) Cutaneous angiosarcoma: update on biology and latest treatment. Curr Opin Oncol 30:107–112. https://doi.org/10.1097/CCO.0000000000000427
Katano A, Yamashita H, Nakagawa K (2021) Radical radiotherapy for localized cutaneous angiosarcoma of the scalp. Mol Clin Oncol 15:195. https://doi.org/10.3892/mco.2021.2357
Hata M, Wada H, Ogino I, Omura M, Koike I, Tayama Y et al (2014) Radiation therapy for angiosarcoma of the scalp: treatment outcomes of total scalp irradiation with X‑rays and electrons. Strahlenther Onkol 190:899–904. https://doi.org/10.1007/s00066-014-0627-z
Miki Y, Tada T, Kamo R, Hosono MN, Tamiya H, Shimatani Y et al (2013) Single institutional experience of the treatment of angiosarcoma of the face and scalp. Br J Radiol 86:20130439. https://doi.org/10.1259/bjr.20130439
Ogawa K, Takahashi K, Asato Y, Yamamoto Y, Taira K, Matori S et al (2012) Treatment and prognosis of angiosarcoma of the scalp and face: a retrospective analysis of 48 patients. Br J Radiol 85:e1127–33. https://doi.org/10.1259/bjr/31655219
Patel SH, Hayden RE, Hinni ML, Wong WW, Foote RL, Milani S et al (2015) Angiosarcoma of the scalp and face: the Mayo Clinic experience. JAMA Otolaryngol Head Neck Surg 141:335–340. https://doi.org/10.1001/jamaoto.2014.3584
Hata M (2018) Radiation therapy for angiosarcoma of the scalp: Total scalp irradiation and local irradiation. Anticancer Res 38:1247–1253. https://doi.org/10.21873/anticanres.12346
Cao J, Wang J, He C, Fang M (2019) Angiosarcoma: a review of diagnosis and current treatment. Am J Cancer Res 29:2303–2313
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Yukihiro Hama, Toshiro Tsukamoto and Etsuko Tate. The first draft of the manuscript was written by Yukihiro Hama and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Y. Hama, T. Tsukamoto and E. Tate declare that they have no competing interests.
Ethical standards
Approval was obtained from the ethics committee of Edogawa Hospital. The procedures used in this study adhere to the tenets of the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hama, Y., Tsukamoto, T. & Tate, E. High-dose planned adaptive helical tomotherapy for cutaneous angiosarcoma of the scalp. Strahlenther Onkol 200, 123–127 (2024). https://doi.org/10.1007/s00066-023-02093-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-023-02093-7